Case reports as early safety signals: learning from the COVID-19 vaccination campaign.
作者信息
Goldman Michel, Chandler Rebecca E
机构信息
I3h Institute, Université libre de Bruxelles, Brussels, Belgium.
Coalition for Epidemic Preparedness Innovations, London, United Kingdom.
出版信息
Front Med (Lausanne). 2024 Jan 9;10:1348376. doi: 10.3389/fmed.2023.1348376. eCollection 2023.
Abstract
摘要
相似文献
1
Case reports as early safety signals: learning from the COVID-19 vaccination campaign.
Front Med (Lausanne). 2024 Jan 9;10:1348376. doi: 10.3389/fmed.2023.1348376. eCollection 2023.
2
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France.
Drug Saf. 2023 Dec;46(12):1381-1389. doi: 10.1007/s40264-023-01359-4. Epub 2023 Nov 5.
3
Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience.
Drug Saf. 2023 Jan;46(1):65-75. doi: 10.1007/s40264-022-01253-5. Epub 2022 Nov 9.
4
Impact of the vaccination against SARS-CoV-2 campaign on disproportionality indicator from the WHO pharmacovigilance database: A competition bias study from case/non-case analysis.
Therapie. 2024 Nov-Dec;79(6):680-691. doi: 10.1016/j.therap.2024.03.002. Epub 2024 Mar 28.
5
[COVID-19 and adenovirus vaccines: French experience of enhanced pharmacovigilance].
Therapie. 2023 Sep-Oct;78(5):489-498. doi: 10.1016/j.therap.2023.01.005. Epub 2023 Jan 21.
6
COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study.
Clin Drug Investig. 2022 Dec;42(12):1065-1074. doi: 10.1007/s40261-022-01216-9. Epub 2022 Oct 23.
7
A case series of bacillus Calmette-Guérin scar reactivation after administration of both mRNA and viral vector COVID-19 vaccines.
Br J Clin Pharmacol. 2023 Jul;89(7):2113-2121. doi: 10.1111/bcp.15678. Epub 2023 Feb 10.
8
Interstitial lung disease following COVID-19 vaccination: a disproportionality analysis using the Global Scale Pharmacovigilance Database (VigiBase).
BMJ Open Respir Res. 2023 Dec 11;10(1):e001992. doi: 10.1136/bmjresp-2023-001992.
9
A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID-19 mRNA vaccination.
Br J Clin Pharmacol. 2023 Mar;89(3):967-981. doi: 10.1111/bcp.15625. Epub 2022 Dec 26.
10
[A retrospective pharmacovigilance analysis: could decreased reporting of suspected adverse reactions generate future safety concerns?].
Recenti Prog Med. 2022 Mar;113(3):198-201. doi: 10.1701/3761.37485.
本文引用的文献
1
Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women.
Sci Adv. 2023 Sep 22;9(38):eadg1391. doi: 10.1126/sciadv.adg1391.
2
Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases.
J Taibah Univ Med Sci. 2023 Sep 5;18(6):1646-1661. doi: 10.1016/j.jtumed.2023.08.004. eCollection 2023 Dec.
3
From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics.
Pharmaceuticals (Basel). 2023 Jul 31;16(8):1088. doi: 10.3390/ph16081088.
4
Approaching hemophagocytic lymphohistiocytosis.
Front Immunol. 2023 Jun 22;14:1210041. doi: 10.3389/fimmu.2023.1210041. eCollection 2023.
5
Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future.
Vaccine. 2023 Jun 7;41(25):3790-3795. doi: 10.1016/j.vaccine.2023.04.055. Epub 2023 May 15.
6
Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination.
Vaccines (Basel). 2023 Mar 17;11(3):696. doi: 10.3390/vaccines11030696.
7
COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review.
BMC Infect Dis. 2023 Jan 6;23(1):7. doi: 10.1186/s12879-022-07973-4.
8
Innate immune mechanisms of mRNA vaccines.
Immunity. 2022 Nov 8;55(11):1993-2005. doi: 10.1016/j.immuni.2022.10.014.
9
Do we miss rare adverse events induced by COVID-19 vaccination?
Front Med (Lausanne). 2022 Oct 10;9:933914. doi: 10.3389/fmed.2022.933914. eCollection 2022.
10
Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis.
J Clin Immunol. 2022 Oct;42(7):1354-1359. doi: 10.1007/s10875-022-01372-9. Epub 2022 Oct 8.
Zotero 插件